Joan Buenconsejo

Latest

• Design and Analysis of Studies Based on Hierarchical Composite Endpoints: Insights from the DARE-19 Trial
• Dapagliflozin and Kidney Outcomes in Hospitalized Patients with COVID-19 Infection
• Power and sample size calculation for the win odds test: application to an ordinal endpoint in COVID-19 trials
• Hierarchical Composite Endpoints: Definition and Analysis Using the Win Ratio (with ties!)
• Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19)
• Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID‐19: Design and rationale for the DARE‐19 study
• Adjusted win ratio with stratification: Calculation methods and interpretation